NFKB1 and acne: Thus, AMPs can be potential candidate for treating acne vulgaris and some of them are reported to show treatment potential for acne vulgaris by direct killing bacteria and inhibiting Toll-like receptor 2 (TLR2)-induced NF-κB activation (Marta Guarna et al., 2006).